Dr. Kumar is a Distinguished University Research Professor and Founding Director of The Center for Convergent Bioscience and Medicine (CCBM), at The University of Alabama in Tuscaloosa. [Legal Name: (First) Ravikumar (Middle) Nagavenkata (Last) Majeti]
Dr. Kumar is known for his significant contributions to the field of rationale design of polyesters and their application to nanomedicines through the authorship of over 100 peer-reviewed publications (Google Scholar). Dr. Kumar was the first to propose and demonstrate non-competitive active targeting nanosystems and its application to human health and diseases. Kumar-lab employed this platform in the treatment of difficult to treat diseases such as lupus, intraocular inflammation in rodent and canine models respectively. His work on the next generation nanosystems has advanced fundamental understanding of GIT-blood and other biological barriers and has led to patentable technologies. These technologies not only allow product life cycle extension, but also can minimize attrition rates if applied early in the drug discovery. His fundamental platform has allowed active collaborations with others across many fields, e.g., comparative medicine (veterinarians), opioid abuse (psychologists), HIV (immunologists), kidney dysfunction (nephrologists), obesity (nutritionists), formulations of NCEs (medicinal chemists) that lead several high impact publications. He runs a productive laboratory, received extramural grants, generated high quality publications and patentable technologies, and supervised a balanced group that includes graduate students, postdoctoral fellows, research faculty and undergraduate students.
Entrepreneurial Initiatives
2023- Peroral Biosciences Inc.,
Co-Founder: Co-founded Peroral Biosciences to develop and commercialize next generation of peroral dosage forms of poorly bioavailable peptides, proteins, and other small molecules. Co-inventor on the intellectual property licensed to the company [US Patent No. 11,504,339 and US Patent No. 10,780,175]. The company has raised seed funding through NuFund Venture group members to conduct feasibility studies enabling the development of proprietary products. [CEO: Sami Shihabi]
Select Awards/Recognitions
2023 President's Faculty Research award, The University of Alabama.
2023 Elected a Corresponding Fellow, Royal Society of Edinburgh (RSE) [Scotland's National Academy of Science].
2023 Elected a Fellow, American Institute of Medical and Biological Engineering (AIMBE).
2022 Elected a Foreign Member, The French National Academy of Pharmacy.
2022 Elected a Fellow, Controlled Release Society (CRS).
2022 Batsheva de Rothschild Fellow, The Israel Academy of Sciences and Humanities.
2022 McCormick Science Institute Research Award, The American Society for Nutrition (ASN) and its Foundation.
2021 Humboldt Research Prize (https://www.humboldt-foundation.de/en/).
2021 Elected a Foreign Member, Academia Europaea (https://www.ae-info.org/).
2021 Featured on The Medicine Maker ‘Power List 20 for 2021’ (https://themedicinemaker.com/power-list/2021).
2020 Elected a Fellow, American Association for the Advancement of Science (AAAS).
2020 Elected a Foreign Fellow, European Academy of Sciences (EurASc, https://www.eurasc.org/user/781/ravikumar-majeti).
2018 Elected a Fellow, American Association of Pharmaceutical Scientists (AAPS).
2018 T. Nagai (Controlled Release Society, USA) Outstanding Researcher Advisor
2009 British Pharmaceutical Conference Science Medal, UK.
2008 Tom Gibson Memorial Award, British Society of Plastic Surgeons & the Royal College of Physicians and Surgeons, UK
2008 Fellow, Royal Society of Chemistry (FRSC), London.
2007 Indian National Science Academy (INSA) Medal for Young Scientist, India.
E-mail: mnvrkumar@ua.edu
Phone: 205-348-2363
Dr. Kumar is known for his significant contributions to the field of rationale design of polyesters and their application to nanomedicines through the authorship of over 100 peer-reviewed publications (Google Scholar). Dr. Kumar was the first to propose and demonstrate non-competitive active targeting nanosystems and its application to human health and diseases. Kumar-lab employed this platform in the treatment of difficult to treat diseases such as lupus, intraocular inflammation in rodent and canine models respectively. His work on the next generation nanosystems has advanced fundamental understanding of GIT-blood and other biological barriers and has led to patentable technologies. These technologies not only allow product life cycle extension, but also can minimize attrition rates if applied early in the drug discovery. His fundamental platform has allowed active collaborations with others across many fields, e.g., comparative medicine (veterinarians), opioid abuse (psychologists), HIV (immunologists), kidney dysfunction (nephrologists), obesity (nutritionists), formulations of NCEs (medicinal chemists) that lead several high impact publications. He runs a productive laboratory, received extramural grants, generated high quality publications and patentable technologies, and supervised a balanced group that includes graduate students, postdoctoral fellows, research faculty and undergraduate students.
Entrepreneurial Initiatives
2023- Peroral Biosciences Inc.,
Co-Founder: Co-founded Peroral Biosciences to develop and commercialize next generation of peroral dosage forms of poorly bioavailable peptides, proteins, and other small molecules. Co-inventor on the intellectual property licensed to the company [US Patent No. 11,504,339 and US Patent No. 10,780,175]. The company has raised seed funding through NuFund Venture group members to conduct feasibility studies enabling the development of proprietary products. [CEO: Sami Shihabi]
Select Awards/Recognitions
2023 President's Faculty Research award, The University of Alabama.
2023 Elected a Corresponding Fellow, Royal Society of Edinburgh (RSE) [Scotland's National Academy of Science].
2023 Elected a Fellow, American Institute of Medical and Biological Engineering (AIMBE).
2022 Elected a Foreign Member, The French National Academy of Pharmacy.
2022 Elected a Fellow, Controlled Release Society (CRS).
2022 Batsheva de Rothschild Fellow, The Israel Academy of Sciences and Humanities.
2022 McCormick Science Institute Research Award, The American Society for Nutrition (ASN) and its Foundation.
2021 Humboldt Research Prize (https://www.humboldt-foundation.de/en/).
2021 Elected a Foreign Member, Academia Europaea (https://www.ae-info.org/).
2021 Featured on The Medicine Maker ‘Power List 20 for 2021’ (https://themedicinemaker.com/power-list/2021).
2020 Elected a Fellow, American Association for the Advancement of Science (AAAS).
2020 Elected a Foreign Fellow, European Academy of Sciences (EurASc, https://www.eurasc.org/user/781/ravikumar-majeti).
2018 Elected a Fellow, American Association of Pharmaceutical Scientists (AAPS).
2018 T. Nagai (Controlled Release Society, USA) Outstanding Researcher Advisor
2009 British Pharmaceutical Conference Science Medal, UK.
2008 Tom Gibson Memorial Award, British Society of Plastic Surgeons & the Royal College of Physicians and Surgeons, UK
2008 Fellow, Royal Society of Chemistry (FRSC), London.
2007 Indian National Science Academy (INSA) Medal for Young Scientist, India.
E-mail: mnvrkumar@ua.edu
Phone: 205-348-2363
The Kumar Lab Team
|
Graduate Students
|
Postdoctoral
|
